Home › Medulloblastoma › Connecticut
Medulloblastoma clinical trials in Connecticut
3 studies for Medulloblastoma are looking for participants at sites in Connecticut.
Cities in Connecticut
Digoxin Medulloblastoma Study
- Connecticut Children's Medical Center, Hartford
RecruitingPhase 2
12 Months – 30 Years · All sexes · Updated Aug 26, 2026 · NCT06701812A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
- Connecticut Children's Medical Center, Hartford
- Yale University, New Haven
RecruitingPhase 3
Ages 4 to 21 · All sexes · Updated Aug 25, 2026 · NCT05382338DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
- Connecticut Children's Hospital, Hartford
RecruitingPhase 2
Up to age 21 · All sexes · Updated Aug 12, 2026 · NCT04696029From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.